SAM
CVS icon

Seelaus Asset Management’s CVS Health CVS Stock Holding History

Seelaus Asset Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,565
Closed -$524K – 178
2024
Q1 		$524K Sell
6,565
-165
-2% -$12.6K 0.52% 61
2023
Q4 		$531K Sell
6,730
-405
-6% -$28.8K 0.52% 62
2023
Q3 		$498K Sell
7,135
-480
-6% -$34K 0.57% 54
2023
Q2 		$526K Sell
7,615
-2,035
-21% -$145K 0.41% 83
2023
Q1 		$735K Sell
9,650
-1,885
-16% -$158K 0.55% 56
2022
Q4 		$1.07M Hold
11,535
– – 0.81% 31
2022
Q3 		$1.1M Sell
11,535
-200
-2% -$19.8K 0.87% 29
2022
Q2 		$1.09M Sell
11,735
-6,622
-36% -$646K 0.81% 31
2022
Q1 		$1.86M Sell
18,357
-5,113
-22% -$537K 1.1% 13
2021
Q4 		$2.42M Sell
23,470
-225
-0.9% -$20.8K 1.31% 11
2021
Q3 		$2.01M Buy
23,695
+2,376
+11% +$199K 1.18% 13
2021
Q2 		$1.78M Buy
21,319
+4,622
+28% +$379K 1.04% 16
2021
Q1 		$1.26M Buy
+16,697
New +$1.22M 0.81% 32

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Seelaus Asset Management's CVS Position: Q2 2024 in Review

Seelaus Asset Management sold out of CVS Health (CVS) in Q2 2024, closing a stake of 6,565 shares — an estimated $524K sold.

Seelaus Asset Management first reported a position in CVS in Q1 2021 and held it in 13 quarters. The position peaked at $2.42M in Q4 2021. 1,911 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Seelaus Asset Management reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Seelaus Asset Management sold 6,565 CVS Health shares in Q2 2024, an estimated $524K.
  • Seelaus Asset Management first reported a position in CVS Health in Q1 2021 and held it in 13 quarters.
  • Seelaus Asset Management's CVS Health position peaked at $2.42M in Q4 2021.
  • 1,911 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Seelaus Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.